Effects of TS-134 on Ketamine-induced BOLD Signals in Healthy Subjects



Status:Completed
Conditions:Healthy Studies
Therapuetic Areas:Other
Healthy:No
Age Range:18 - 55
Updated:5/2/2018
Start Date:June 28, 2017
End Date:April 10, 2018

Use our guide to learn which trials are right for you!

A Randomized, Single-blind, Parallel-group Study to Evaluate the Effects of TS-134 on Ketamine-induced BOLD Signals in Resting fMRI in Healthy Adult Subjects

The purpose of this study is to evaluate the effects of TS-134 on ketamine-induced BOLD
signals in ROIs in resting fMRI in healthy adult subjects.


Inclusion Criteria:

- Healthy adult male and female subjects between 18 and 55 years of age inclusive (at
the time of initial informed consent)

- Body weight ≥ 45 and ≤ 87 kg

- Body Mass Index (BMI) ≥ 18 and ≤ 30 kg/m2

Exclusion Criteria:

- Female subjects who are pregnant, intend to become pregnant, or are breastfeeding

- History or presence of psychiatric or neurologic disease or condition

- History of first-degree relative with schizophrenia or mood disorder with psychosis

- History of alcohol or drug abuse

- History of recreational ketamine use, recreational PCP use, or an adverse reaction to
ketamine

- History of violence

- Presence or positive history of significant medical illness, including high blood
pressure, low blood pressure or orthostatic hypotension

- Any subjects who show subthreshold ketamine BOLD response

- Metal implants, pacemaker, other metal or paramagnetic objects contained within the
body

- Claustrophobia

- Subject with any history of suicidal behavior or is currently at risk of suicide in
the opinion of the investigator
We found this trial at
1
site
1051 Riverside Dr
New York, New York 10032
646-774-5000
Phone: 646-774-8436
New York State Psychiatric Institute The New York State Psychiatric Institute (NYSPI), established in 1895,...
1290
mi
from
New York, NY
Click here to add this to my saved trials